⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23546 | 0.71 | — | — | |
| SCHEMBL702020 | 0.71 | — | — | |
| SCHEMBL571282 | 0.69 | — | — | |
| SCHEMBL571281 | 0.69 | — | — | |
| Ammonia Solution, Strong SCHEMBL7121772 | 0.67 | — | — | |
| SCHEMBL27751093 | 0.67 | — | — | |
| SCHEMBL18783524 | 0.67 | — | — | |
| SCHEMBL10458007 | 0.67 | — | — | |
| Water SCHEMBL27372388 | 0.67 | — | — | |
| SCHEMBL11655335 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4223823-A1 | NOVEL POLYURETHANES HAVING PENDANT EPOXY GROUPS AND THERMOSETS THEREOF | Covestro LLC (US) | 2023-08-09 | — | — | EP | claimed |
| WO-2023114645-A1 | NOVEL POLYURETHANES HAVING PENDANT EPOXY GROUPS AND THERMOSETS THEREOF | COVESTRO LLC (US) | 2023-06-22 | — | — | WO | claimed |
| EP-3254675-B1 | DELAYED RELEASE, ORAL DOSAGE COMPOSITIONS THAT CONTAIN AMORPHOUS CDDO-ME | REATA PHARMACEUTICALS INC (US) | 2019-05-15 | — | — | EP | claimed |
| US-9155721-B2 | Delayed release, oral dosage compositions that contain amorphous CDDO-Me | REATA PHARMACEUTICALS, INC. (US) | 2015-10-13 | — | — | US | claimed |
| US-20140235711-A1 | DELAYED RELEASE, ORAL DOSAGE COMPOSITIONS THAT CONTAIN AMORPHOUS CDDO-ME | REATA PHARMACEUTICALS, INC. (US) | 2014-08-21 | — | — | US | claimed |
| EP-1490356-B1 | (3Z)-3-(3-HYDRO-ISOBENZOFURAN-1-YLIDENE)-1,3-DIHYDRO-2H-INDOL-2-ONES AS KINASE INHIBITORS | ALLERGAN INC (US) | 2013-02-27 | — | — | EP | claimed |
| US-20120022156-A1 | DELAYED RELEASE, ORAL DOSAGE COMPOSITIONS THAT CONTAIN AMORPHOUS CDDO-ME | REATA PHARMACEUTICALS, INC. (US) | 2012-01-26 | — | — | US | claimed |
| WO-2010093944-A2 | DELAYED RELEASE, ORAL DOSAGE COMPOSITIONS THAT CONTAIN AMORPHOUS CDDO-ME | REATA PHARMACEUTICALS, INC. (US) | 2010-08-19 | — | — | WO | claimed |
| US-20090105292-A9 | Glucocorticoid Receptor Modulator Compounds and Methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2009-04-23 | — | — | US | claimed |
| US-20070281959-A1 | Glucocorticoid receptor modulator compounds and methods | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2007-12-06 | — | — | US | claimed |
| EP-1218358-A1 | THERAPEUTIC QUINAZOLINE COMPOUNDS | AstraZeneca AB (SE) | 2002-07-03 | — | — | EP | claimed |
| US-6399603-B1 | QUINAZOLINES; RETARDING APOPTOSIS IN CELLS; INHIBITING CLEAVAGE OF PROTEIN SUBSTRATES BY CASPASE-3; CHEMICAL AND HYDROLYTIC STABILITY | ASTRAZENECA AB (SE) | 2002-06-04 | — | — | US | claimed |
| EP-0586474-B1 | PEPTIDE NUCLEIC ACIDS | BUCHARDT OLE (DK) | 2001-09-12 | — | — | EP | claimed |
| WO-2001021598-A1 | THERAPEUTIC QUINAZOLINE COMPOUNDS | ASTRAZENECA AB (SE) | 2001-03-29 | — | — | WO | claimed |
| WO-1999039914-A1 | INK RECEPTIVE SHEET | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-08-12 | — | — | WO | claimed |
| US-5068140-A | Transparencies | XEROX CORPORATION (US) | 1991-11-26 | — | — | US | claimed |
| EP-0450480-A2 | Somatostatin Analogues | The Administrators of The Tulane Educational Fund (US) | 1991-10-09 | — | — | EP | claimed |
| EP-0100200-B1 | 2-SUBSTITUTED 4-AMINO-6,7-DIMETHOXYQUINOLINES | Pfizer Limited (GB) | 1987-05-06 | — | — | EP | claimed |
| EP-0083960-B1 | SPRAYABLE ACOUSTICAL COMPOSITION | UNITED STATES GYPSUM COMPANY (US) | 1985-11-27 | — | — | EP | claimed |
| EP-0100200-A1 | 2-Substituted 4-amino-6,7-dimethoxyquinolines | Pfizer Limited (GB) | 1984-02-08 | — | — | EP | claimed |